Amanote Research
Register
Sign In
A Phase I Trial of Intratumoral Administration of Recombinant Oncolytic Adenovirus Overexpressing HSP70 in Advanced Solid Tumor Patients
Gene Therapy
- United Kingdom
doi 10.1038/gt.2008.179
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Genetics
Molecular Biology
Date
December 25, 2008
Authors
J-L Li
H-L Liu
X-R Zhang
J-P Xu
W-K Hu
M Liang
S-Y Chen
F Hu
D-T Chu
Publisher
Springer Science and Business Media LLC
Related search
273. Phase I Trial of Escalating Doses of SGT-53 Infusion in Combination With Docetaxel in Advanced Solid Tumor Patients
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
A Phase I Trial of SJG-136 (NSC#694501) in Advanced Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Phase I/Ii Trial of Pemetrexed Plus Nab-Paclitaxel in Advanced Solid Tumor Patients With Emphasis on Non-Small Cell Lung Cancer
Investigational New Drugs
Oncology
Pharmacology
A Phase I Trial of Ispinesib, a Kinesin Spindle Protein Inhibitor, With Docetaxel in Patients With Advanced Solid Tumours
British Journal of Cancer
Cancer Research
Oncology
774. Phase Ib Trial of Escalating Doses of SGT-53 Infusion in Combination With Docetaxel in Advanced Solid Tumor Patients
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
A Phase 1 Study of Cetuximab and Lapatinib in Patients With Advanced Solid Tumor Malignancies
Cancer
Cancer Research
Oncology
A Phase I Study of NLG919 for Adult Patients With Recurrent Advanced Solid Tumors
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
A Phase I Trial of Combination Trastuzumab, Lapatinib, and Bevacizumab in Patients With Advanced Cancer
Investigational New Drugs
Oncology
Pharmacology